SLC7A11 and neurodegenerative disease: In many neurological conditions, such as inflammation/degenerative diseases (Pampliega et al., 2011), hypoxic diseases (Jackman et al., 2010), epilepsy and brain tumors (Lewerenz et al., 2014), the transcription of the Slc7a11 gene is increased.